Health & Medicine - Page 7 of 11

Details of the final analysis of the phase III ASPEN trial, which compared zanubrutinib and ibrutinib in symptomatic patients with Waldenström’s macroglobulinemia, were published in the Journal of Clinical Oncology by Meletios A. Dimopoulos, MD, and colleagues.

ShareFacebook TwitterLinkedinTelegramEmailClipboard

MD Anderson ranked #1 in the nation for cancer care

The University of Texas MD Anderson Cancer Center today was named number one in the nation for cancer care in U.S. News & World Report’s 2023-24 “Best Hospitals” survey. The institution has been one of the nation’s top two hospitals for cancer care since the survey’s…

national cancer institute NFvdKIhxYlU unsplash(2)

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

We are proud to have another publication in WM: “Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study,” (Journal of Clinical Oncology, 21/7/2023)

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

FDA approves first over-the-counter birth control pill in U.S. – The Washington Post

Federal regulators Thursday approved the first over-the-counter birth control pill available in the United States, a milestone in decades-long efforts to make oral contraceptives easier to obtain, especially by teenagers and women who don’t regularly see a doctor.

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

International distinction for the Laboratory of the Therapeutic Clinic of the School of Medicine of the National and Kapodistrian University of Athens

Dr Tina Bagratuni and Prof. Meletios A. Dimopoulos were selected for funding from the highly competitive program of International Waldenstrom’s Macroglobulinemia Foundation (IWMF), the IWMF-LLS Strategic Research Roadmap Initiative. The title of the funded project is the “Genomic characterization of ibrutinib-resistant WM”,…

Events Health & Medicine University Community

ShareFacebook TwitterLinkedinTelegramEmailClipboard

16th STATE OF THE ART Adolescent Health/Medicine Congress [13-14/10/23]

The 16th STATE OF THE ART Adolescent Health/Medicine Congress will be held in Athens on October 13 and 14, 2023, at the NKUA’s ‘Ioannis Drakopoulos’ Amphitheatre. Its main theme will be the ‘Well-being of Children and Adolescents’, and participation will be free of charge.

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

The Hemato-Oncology Course by the National and Kapodistrian University of Athens in collaboration with Mayo Clinic (USA) was successfully concluded

An important Hemato-Oncology Course was held by the National and Kapodistrian University of Athens in collaboration with Mayo Clinic, USA in Athens from Thursday June 29 to July 1.

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

Mayo Clinic: The past, the Present and the Future | Rafael Fonseca (US), Stephen Ansell (US), Tanios Bekaii-Saab (US) -Session moderated by Panos Savvides (US)

3 senior leaders of the MAYO Clinic will share with us their insights on the past, the present and the future of the MAYO Clinic.

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

Mayo Clinic and National and Kapodistrian University of Athens: Hematology and Oncology Course

Thursday June 29, 2023 was the first day of “Mayo Clinic and National and Kapodistrian University of Athens: Hematology and Oncology Course with updates of ASCO and EHA on Oncology and Hematology”.

Distinctions Health & Medicine University Community

ShareFacebook TwitterLinkedinTelegramEmailClipboard

Professor of NKUA George Papatheodoridis received the EASL Recognition Award 2023

Mr George Papatheodoridis, Professor at the National and Kapodistrian University of Athens, received the EASL Recognition Award 2023, the highest European distinction for achievement in Hepatology. Professor Papatheodoridis is only the second Greek to accomplish this, the first being Professor Stephanos Hadziyiannis.